Skip to main content

Table 1 Clinicla data of the patients in the study

From: In vitro analysis of the proliferative capacity and cytotoxic effects of ex vivo induced natural killer cells, cytokine-induced killer cells, and gamma-delta T cells

Patients no.

Gender

Age

Type of tumor

Stages of disease

1

Female

36

Gastric Cancer

IB(T2N0M0)

2

Male

65

Gastric Cancer

IV(T4bN0M1)

3

Male

80

Gastric Cancer

IV (rcTxNxM1)

4

Female

71

Gastric Cancer

IIA (T3N0M0)

5

Female

39

Gastric Cancer

IIB (T1bN3aM0)

6

Male

66

Kidney Cancer

(T1aNxMx)

7

Male

62

Kidney Cancer

(T4NxM0)

8

Female

59

Breast Cancer

IV (pT1N1M1)

9

Female

49

Breast Cancer

I (pT1N0M0)

10

Female

49

Breast Cancer

I (pT1cN0M0)

11

Female

56

Breast Cancer

I (pT1N0M0)

12

Male

61

Liver Cancer

C (BCLC)

13

Male

71

Liver Cancer

IV (Intrahepatic cholangiocellular carcinoma)

14

Male

80

Liver Cancer

Early A (BCLC)

15

Female

63

Lung Cancer

IB (pT2aN0M0)

16

Male

50

Lung Cancer

IIIA (pT2aN2M0)

17

Male

43

Lung Cancer

IB (pT2N0M0)

18

Male

68

Lung Cancer

IIB (pT3N0M0)

19

Female

56

Lung Cancer

(pTisN0M0)

20

Female

69

Lung Cancer

Extended stage